Assessment of Circulating Tumor Cells and microRNAs in Patients With Metastatic Non-cutaneous Melanoma

Active, not recruitingOBSERVATIONAL
Enrollment

35

Participants

Timeline

Start Date

May 24, 2023

Primary Completion Date

September 30, 2024

Study Completion Date

March 31, 2025

Conditions
Melanoma Neoplasms
Trial Locations (1)

40138

IRCCS Azienda Ospedaliero-Universitaria di Bologna, Bologna

All Listed Sponsors
lead

IRCCS Azienda Ospedaliero-Universitaria di Bologna

OTHER